Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Dendreon Data Are Merely Moderate, But Stock Surges Anyway
Dendreon Data Are Merely Moderate, But Stock Surges Anyway
Dendreon Data Are Merely Moderate, But Stock Surges Anyway
Submitted by
admin
on November 11, 2010 - 9:00am
Source:
Forbes
News Tags:
Provenge
vaccines
Dendreon
prostate cancer
Headline:
Dendreon Data Are Merely Moderate, But Stock Surges Anyway
Do Not Allow Advertisers to Use My Personal information